Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Merck Serono and EPFL announce neuroscience, oncology and drug delivery partnership

Merck Serono, a division of Merck KGaA, and EPFL (Ecole Polytechnique Fédérale de Lausanne), one of the two Swiss Federal Institutes of Technology, announced the signing of a research collaboration agreement in the areas of Neuroscience, Oncology and Drug Delivery. Under this agreement, three Merck Serono-endowed Chairs will be created at EPFL: in neurodegenerative diseases, such as Alzheimer's and Parkinson's; in cancer, in the framework of the Swiss Institute for Experimental Cancer Research (ISREC); and in innovative drug delivery technologies, for instance nanoparticle vaccines.

1 Nov 2007

Radiation after surgery keeps high-risk prostate cancer at bay

An analysis of data involving more than 2,000 patients from 17 U.S. institutions demonstrates that men with high-risk prostate cancer who receive radiation therapy after a prostatectomy were less likely to have a recurrence of disease.

31 Oct 2007

Quality of life most important for survival in advanced non-small cell lung patients

Healthcare providers have observed it for years -- patients who appear to have a better quality of life while battling their cancer live longer.

31 Oct 2007

Men, don't skip your prostate cancer treatment appointments!

Men with “low risk” prostate cancer who miss more than two radiation treatments in an eight week treatment face an increased chance of their cancer recurring.

31 Oct 2007

Stereotactic radiation is effective as surgery against nerve tumor

Specifically aimed, "stereotactic" radiation may be as good as surgery - and in some cases, even better - in treating benign but potentially devastating brain tumors called non-acoustic schwannomas, according to a study by rradiation oncologists at the Kimmel Cancer Center at Thomas Jefferson University and Thomas Jefferson University Hospital in Philadelphia.

31 Oct 2007

Breast cancer victims who smoke not at risk for more aggressive tumors

According to a new study women who develop breast cancer and smoke are not at an increased risk of developing more aggressive or advanced tumors.

31 Oct 2007

Children would need different medical care in wake of dirty bomb

If terrorists were to attack with a dirty bomb, medical authorities should be prepared to treat children differently than adults because their developing bodies would absorb and respond to the radiation exposure in distinct ways, according to a new study from the University of Rochester Medical Center.

31 Oct 2007

Which lung volumes to use for radiotherapy planning of lung cancer

A new method to standardize the reporting of radiation dose volumes in the use of four-dimensional computed tomography (4D-CT) can lead to a more accurate radiation dose to the lungs in lung cancers, thereby lowering the risk of lung injury, according to a study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

29 Oct 2007

Brachytherapy effectively cures prostate cancer in young men

Radiation seed implants (brachytherapy) are just as effective at curing prostate cancer in younger men (aged 60 and younger) as they are in older men, according to a study presented at a scientific session on October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

29 Oct 2007

Radiation plus chemo quadruples survival time for fatal brain cancer

Over four times as many patients with a rapidly fatal type of brain cancer, glioblastoma multiforme (GBM), who are treated with the chemotherapy drug temozolomide (TMZ) and radiation therapy, can live for four years after diagnosis, compared to those who receive only radiation treatment, according to updated results of a large, international trial presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

29 Oct 2007

Preventing lung scarring may extend lives of lung cancer patients

Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients – pulmonary fibrosis (scarring of the lungs), thereby extending patients' lives and improving their quality of life, according to a study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

29 Oct 2007

Higher radiation doses over shorter periods of time for prostate cancer doesn't lead to sexual dysfunction

Recent advances in the delivery of radiation therapy for prostate cancer are fueling a new trend of providing higher radiation doses over shorter periods of time.

29 Oct 2007

Extra radiation dose prevents breast cancer return in young women

Women 40 years and younger with early-stage breast cancer who receive an additional high dose of radiation (boost dose) after undergoing breast-conserving surgery (lumpectomy) and standard radiation treatment are almost twice as likely to be free of cancer 10 years after treatment compared to those who don't receive the boost dose, according to a large European study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

29 Oct 2007

Do statins make radiation more effective at curing prostate cancer?

Patients with prostate cancer who receive high-dose radiation treatment and also take statin drugs commonly used to lower cholesterol have a 10 percent higher chance of being cured of their cancer at 10 years after diagnosis (76 percent), compared to those who don't take these medications (66 percent), according to a study presented at a scientific session October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

29 Oct 2007

Study confirms the aggressive nature of breast cancer in African-American women

Contrary to previous studies, African-American women with early-stage breast cancer who have surgery to remove the cancer (lumpectomy) followed by radiation therapy have a higher chance of their cancer coming back in the breast and lymph nodes 10 years after diagnosis, compared to their Caucasian counterparts, according to the largest study of its kind, presented at a scientific session October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

29 Oct 2007

Women with breast cancer have less dermatitis when treated with intensity-modulated radiation therapy

All women treated with radiation therapy for breast cancer are at risk of developing dermatitis - a sometimes-painful skin condition caused by radiation as it makes its way through the skin to the tumor area and tissue within the breast.

28 Oct 2007

Walking prevents bone loss caused from prostate cancer treatment

Exercise may reduce, and even reverse, bone loss caused by hormone and radiation therapies used in the treatment of localized prostate cancer, thereby decreasing the potential risk of bone fractures and improving quality of life for these men, according to a study presented on October 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

28 Oct 2007